(MedPage Today) -- Use of an alternative for a chemotherapy drug that was in short supply appears to have hurt outcomes for kids with Hodgkin lymphoma, an analysis suggested. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment